Summary: 60 Minutes Australia reports on promising results from clinical trials of MDMA-assisted psychotherapy for PTSD and speaks with MAPS Director of Strategic Communications, Brad Burge, to learn more. Burge explains the therapeutic potential of the treatment is attributed to the combination of therapy with MDMA, not the drug alone. “What MAPS is developing is not just MDMA as a medicine, what we’re developing is MDMA-assisted psychotherapy,” explains Brad Burge.
Originally appearing here.
